Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 23376459)

1.

Influence of donor specific HLA antibodies detected by Luminex in kidney graft survival: a multivariate analysis.

Caro-Oleas JL, González-Escribano MF, Gentil-Govantes MA, Acevedo MJ, González-Roncero FM, Bernal-Blanco G, Núñez-Roldán A.

Hum Immunol. 2013 May;74(5):545-9. doi: 10.1016/j.humimm.2013.01.010. Epub 2013 Jan 29.

PMID:
23376459
2.
3.

Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.

Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.

Nephrol Dial Transplant. 2012 Mar;27(3):1231-8. doi: 10.1093/ndt/gfr429. Epub 2011 Aug 2.

4.

Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.

Billen EV, Christiaans MH, van den Berg-Loonen EM.

Tissue Antigens. 2009 Sep;74(3):205-12. doi: 10.1111/j.1399-0039.2009.01283.x. Epub 2009 Jun 2.

PMID:
19497037
5.

Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.

Laging M, Kal-van Gestel JA, Haasnoot GW, Claas FH, van de Wetering J, Ijzermans JN, Weimar W, Roodnat JI.

Transplantation. 2014 Feb 15;97(3):330-6. doi: 10.1097/01.TP.0000435703.61642.43.

PMID:
24202143
6.

Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.

Ntokou IS, Iniotaki AG, Kontou EN, Darema MN, Apostolaki MD, Kostakis AG, Boletis JN.

Transpl Int. 2011 Nov;24(11):1084-93. doi: 10.1111/j.1432-2277.2011.01312.x. Epub 2011 Aug 16.

PMID:
21848902
7.

A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.

Bingaman AW, Murphey CL, Palma-Vargas J, Wright F.

Transplantation. 2008 Dec 27;86(12):1864-8. doi: 10.1097/TP.0b013e318191404c.

PMID:
19104435
8.

Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.

Kanter Berga J, Sancho Calabuig A, Gavela Martinez E, Puig Alcaraz N, Beltran Catalan S, Avila Bernabeu A, Crespo Albiach J, Montoro JA, Pallardo Mateu LM.

Transplant Proc. 2012 Nov;44(9):2529-31. doi: 10.1016/j.transproceed.2012.09.102.

PMID:
23146444
9.
10.

Pre-transplant donor specific antibody and its clinical significance in kidney transplantation.

Thammanichanond D, Ingsathit A, Mongkolsuk T, Rattanasiri S, Kantachuvesiri S, Sakhonrat C, Leenanupan C, Worawichawongs S, Kitpoka P.

Asian Pac J Allergy Immunol. 2012 Mar;30(1):48-54.

11.

Luminex-based virtual crossmatching for renal transplantation in South Africa.

Worsley CM, Mayne ES, Suchard MS.

S Afr Med J. 2011 Dec 14;102(1):40-3.

PMID:
22273137
12.

Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.

Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.

Transplantation. 2009 Jan 27;87(2):227-32. doi: 10.1097/TP.0b013e31818c962b.

PMID:
19155977
13.

The impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study.

David-Neto E, Souza PS, Panajotopoulos N, Rodrigues H, Ventura CG, David DS, Lemos FB, Agena F, Nahas WC, Kalil JE, Castro MC.

Clinics (Sao Paulo). 2012;67(4):355-61.

14.

Transplantation with positive complement-dependent microcytotoxicity crossmatch in contemporary kidney transplantation: Practice patterns and associated outcomes.

Graff RJ, Xiao H, Duffy B, Schnitzler MA, Axelrod D, Lentine KL.

Saudi J Kidney Dis Transpl. 2012 Mar;23(2):234-45.

15.

Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.

Castillo-Rama M, Castro MJ, Bernardo I, Meneu-Diaz JC, Elola-Olaso AM, Calleja-Antolin SM, Romo E, Morales P, Moreno E, Paz-Artal E.

Liver Transpl. 2008 Apr;14(4):554-62. doi: 10.1002/lt.21408.

16.

Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.

Kuo HT, Huang E, Emami S, Pham PT, Wilkinson AH, Danovitch GM, Bunnapradist S.

Transplantation. 2012 Mar 15;93(5):493-502. doi: 10.1097/TP.0b013e3182427fc3.

PMID:
22306574
17.

Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.

Mahmoud KM, Ismail AM, Sheashaa HA, Gheith OA, Kamal MM, Ghoneim MA.

Exp Clin Transplant. 2009 Jun;7(2):124-8.

PMID:
19715518
18.

Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.

Morris GP, Phelan DL, Jendrisak MD, Mohanakumar T.

Hum Immunol. 2010 Mar;71(3):268-73. doi: 10.1016/j.humimm.2010.01.003. Epub 2010 Jan 25.

PMID:
20074605
19.

Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.

Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.

Transplant Proc. 2012 Jun;44(5):1231-5. doi: 10.1016/j.transproceed.2011.10.054.

PMID:
22663991
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk